Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
— Overall survival (OS) results from BRACELET-1 corroborate results of previous randomized IND-213 breast cancer study — Together, these two studies support the compelling potential ofpelareorep-based combination therapy to benefit patients with advanced or metastatic HR+/HER2- breast cancer — Oncolytics Biotech is moving forward to secure funding for a registration-enabling study of pelareorep-based therapy in […]